News | Information Technology | March 08, 2017

Frost & Sullivan Analysis Projects Transformative Year for Healthcare in 2017

Value-based care continues to transform industry, driving need for targeted therapies

Frost & Sullivan, Healthcare Industry Outlook 2017 analysis, information technology, healthcare IT

March 8, 2017 — Despite global political uncertainties and a sluggish economic outlook for 2017, the global healthcare industry is set for an invigorating year, according to a new analysis from Frost & Sullivan. This outlook is due to a partial realization of major healthcare policies and initiatives, technology advancements and value-based care driving the adoption and need for consumer-centric targeted therapies. Future drugs and medical devices will be more targeted to meet the unique needs of emerging markets (e.g. China, India, Brazil) which demonstrate high growth opportunities compared developed markets (e.g., the United States and Western Europe. Growing at a CAGR of 4.8 percent, the industry is likely to reach revenue of $1,731.8 billion.

Current predictions and trends from the analysis encouraging transformation include:

  • Growth in remote patient monitoring (RPM) will start to accelerate beyond previous projections based on a convergence of regulatory, technology and ergonomic factors;
  • A selective churn in the mobile health app space will differentiate the small number of vetted apps that will emerge as the best choice for serious health users;
  • Life sciences and device industries will experience an increase in collaboration as well as merger and acquisition activities as they design products to prevent the onset of chronic and degenerative diseases;
  • Artificial intelligence (AI) will play an important role in helping radiologists better interpret scans, reduce scan times, improve workflow efficiency and improve quality. AI will also make medical implants smarter as a way to intelligently regulate specific health conditions;
  • Alternate payment models will drive the demand for next-generation revenue cycle management solutions. The adoption of alternative payment models will drive the usage of robust and agile analytics software that automates reporting and visualization of patient-specific information;
  • Immunotherapy will become part of the toolbox for treatment of various types of cancers. Immuno-oncology will remain hot as leading pharmaceutical companies race to market the first chimeric antigen receptor T-cell (CAR-T) therapy in 2017; and
  • Decreasing cost of next-generation sequencing tests to below the $1,000 mark will shift the application focus from research to clinical use cases.

The new analysis, Healthcare Industry Outlook, 2017, which is part of Frost & Sullivan’s Advanced Medical Technologies Growth Partnership Service program, explores how the global healthcare landscape is expected to evolve in 2017. It identifies key trends impacting the industry from lifesciences, medical technologies, remote patient monitoring, healthcare information technologies, care delivery and business model perspectives.

“2017 will be a tipping point for mainstream adoption of popular digital health solutions (e.g., wearables, telehealth), and transition of noble technologies from research to actionable clinical applications (e.g. POCT Dx tools, AI, robotics, and image-guided therapies),” noted Frost & Sullivan Transformational Health Research Analyst Kamaljit Behera.

For more information: www.frost.com

Related Content

Affordable Care Act Ruled Unconstitutional in Texas Federal Court
News | Radiology Business | December 17, 2018
A judge of the Federal District Court for the Northern District of Texas ruled the Affordable Care Act (ACA)...
Nicklaus Children's Hospital Launches Enterprise Mobile Clinical Collaboration Platform
News | Enterprise Imaging | December 17, 2018
Enterprise imaging health information technology (IT) provider Dicom Systems Inc. announced a new joint deployment with...
Videos | Enterprise Imaging | December 14, 2018
ITN Editor Dave Fornell and ITN Contributing Editor Greg Freiherr share their insights on the vendors highlighting EI
RADxx Announces 2nd Annual Award Winners for Outstanding Leadership in Medical Imaging Informatics
News | Radiology Business | December 14, 2018
RAD Women (#RADxx), a networking group for the advancement of women in imaging informatics, recently announced the...
Videos | Artificial Intelligence | December 13, 2018
ITN Editor Dave Fornell and ITN Contributing Editor Greg Freiherr share their insights on the vendors showing AI prod
Guerbet Showcases Diagnostic and Interventional Imaging Solutions at RSNA 2018
News | Interventional Radiology | December 12, 2018
Guerbet LLC USA highlighted new and next-level product offerings and partnerships in contrast media, injectors,...
Lunit Announces New Prominent Radiology Advisory Board Members
News | Artificial Intelligence | December 11, 2018
Medical artificial intelligence (AI) software company Lunit announced three new members of its advisory board,...
Coreline Soft Introduces AI Lung Segmentation Solution at RSNA 2018
News | Lung Cancer | December 10, 2018
December 10, 2018 — Korean image software company Coreline Soft Co. Ltd.
FDA Clears iCAD's ProFound AI for Digital Breast Tomosynthesis
Technology | Mammography | December 07, 2018
iCAD Inc. announced clearance by the U.S. Food and Drug Administration (FDA) for their latest, deep-learning, cancer...